Valeant Will Release Third-Quarter 2017 Financial Results On November 7

LAVAL, Quebec, Oct. 3, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant") will release its third-quarter 2017 financial results on Tuesday, Nov. 7, 2017. Valeant will host a conference call and live web cast at 8:00 a.m. EST to discuss the results and provide a business update. All materials will be made available on the investor relations section of the Valeant web site prior to the start of the call.

Conference Call Details

    Date:                      Tuesday, Nov. 7, 2017

    Time:                      8:00 a.m. EST


    Participant Event Dial-in: (844) 428-3520 (North America)

                               (409) 767-8386 (International)

    Participant Passcode:                                                     91700211

    Replay Dial-in:            (855) 859-2056 (North America)

                               (404) 537-3406 (International)

    Replay Passcode:           91700211 (replay available until Jan. 7, 2018)

About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant can be found at

    Investor Contact:          Media Contact:

    Arthur Shannon             Lainie Keller

    (514) 856-3855             (908) 927-0617

    (877) 281-6642 (toll free)

View original content with multimedia:

SOURCE Valeant Pharmaceuticals International, Inc.